UNSPSC 51182104: Felypressin

This classification denotes an antidiurectic hormone analogue with the molecular formula C46H65N13O11S2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 17N2918V6G, chemically known as vasopressin, 2-l-phenylalanine-8-l-lysine- but generally known as felypressin, which bears US NIH Compound Identifier 5956. European Medicines Agency schedules Felypressin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07529MIG.

UNSPSC 51182104 Felypressin is a Commodity code covering a synthetic vasopressin analog used primarily in surgical and clinical settings to control bleeding and manage certain endocrine conditions. State and local governments procure felypressin through their health systems, correctional medical departments, and public hospitals as a prescription pharmaceutical requiring specialized storage and handling. The product appears in procurement primarily as part of broader pharmaceutical supply contracts or emergency medical inventory requisitions rather than as a standalone good, reflecting its role as a critical but lower-volume surgical agent within larger formularies.

The source provided contains no recent state or local contract opportunities tagged to this code, making it impossible to characterize issuing-body mix, geographic spread, or representative solicitations. The absence of recent activity under this Commodity code may reflect either limited state and local demand for felypressin specifically, procurement through centralized pharmaceutical cooperative agreements that use higher-tier family codes for visibility, or tagging variance across jurisdictions. Business development professionals should verify whether opportunities for this product surface under broader pharmaceutical supply or surgical-supply family codes, or whether state health system cooperative purchasing vehicles (such as those managed by regional GPOs) handle felypressin procurement outside traditional competitive RFP processes.